亚盛医药:全球化战略加速,双引擎驱动商业化高速发展

21世纪经济报道
02 Apr

“面对生物医药产业的挑战,我相信今年将是一个新的起点和转折点。我也坚信,健康始终是一个朝阳行业,尤其是在中国经过三四十年的改革开放后,我们已经建立了坚实的经济基础,拥有优质的人才和巨大的市场需求。”近日,亚盛医药董事长、CEO杨大俊在2024年业绩公布之际表示,相信生物医药在未来几年将迎来突破,更多地满足中国和全球患者的需求,促使中国的技术走向世界,获得更多国际认可和市场份额,也为所有投资人带来...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10